Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG) (Q34907190)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG)	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG) (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Anastasia G Eleftheraki

object named as

Anastasia G Eleftheraki

3

0 references

object named as

Mattheos Bobos

8

0 references

Athanasios Dimopoulos

object named as

Meletios A Dimopoulos

9

0 references

George Fountzilas

22

object named as

George Fountzilas

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Anna Batistatou

7

object named as

Anna Batistatou

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Vassiliki Kotoula

2

object named as

Vassiliki Kotoula

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

11

object named as

Helen Gogas

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Konstantine T Kalogeras

6

object named as

Konstantine T Kalogeras

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Dimitrios Pectasides

20

object named as

Dimitrios Pectasides

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Epaminontas Samantas

19

object named as

Epaminontas Samantas

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Helena Linardou

18

object named as

Helena Linardou

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Eleni Timotheadou

10

object named as

Eleni Timotheadou

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

George Pentheroudakis

1

object named as

George Pentheroudakis

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ioannis Efstratiou

14

object named as

Ioannis Efstratiou

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Eleftheria Tsolaki

4

object named as

Eleftheria Tsolaki

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Nicholas Pavlidis

21

object named as

Nicholas Pavlidis

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

5

object named as

Ralph M Wirtz

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Chrisoula D Scopa

15

object named as

Chrisoula D Scopa

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Kyriaki Papadopoulou Legbelou

13

object named as

Kyriaki Papadopoulou

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Christos Christodoulou

12

object named as

Christos Christodoulou

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Irene Papaspyrou

16

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Dimitrios Vlachodimitropoulos

17

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

29 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

e70634

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

29 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

Gene amplification of ESR1 in breast cancers--fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

ESR1 gene amplification in breast cancer: a common phenomenon?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

Selection of adjuvant chemotherapy for treatment of node-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

Feasibility of simultaneous fluorescence immunophenotyping and fluorescence in situ hybridization study for the detection of estrogen receptor expression and deletions of the estrogen receptor gene in breast carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

8 July 2018

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070634

21 January 2018

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070634

21 January 2018

Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070634

21 January 2018

Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070634

21 January 2018

REporting recommendations for tumor MARKer prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0070634

21 January 2018

ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3726626

26 October 2018

ESR1 gene amplification in breast cancer: a common phenomenon?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23923010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ESR1 gene amplification in breast cancer: a common phenomenon?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23923010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ESR1 gene amplification in breast cancer: a common phenomenon?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23923010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://pubmed.ncbi.nlm.nih.gov/23923010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23923010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23923010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0070634

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2013PLoSO...870634P

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34907190&oldid=2051757278"